Potential of telomerase-specific oncolytic adenovirus as an immunogenic drug producing synergy with anti-PD-1 therapy

被引：0
|
作者：
Kanaya, Nobuhiko [1 ]
Kuroda, Shinji [1 ]
Morihiro, Toshiaki [1 ]
Kubota, Tetsushi [1 ]
Tazawa, Hiroshi [1 ]
Kikuchi, Satoru [1 ]
Nishizaki, Masahiko [1 ]
Kagawa, Shunsuke [1 ]
Urata, Yasuo [2 ]
Fujiwara, Toshiyoshi [1 ]
机构：
[1] Okayama Univ, Dept Grastroenterol Surg, Okayama, Japan
[2] Oncolys BioPharma Inc, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Oncolytic virus; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3178
引用
收藏
页码：1059 / 1059
页数：1
相关论文
共 50 条
  • [1] Telomerase-specific oncolytic adenovirus amplifies immunogenic effects with anti-PD1 antibody
    Hashimoto, Masashi
    Kuroda, Shinji
    Kanaya, Nobuhiko
    Yagi, Chiaki
    Tsumura, Tomoko
    Kumon, Kento
    Kakiuchi, Yoshihiko
    Kikuchi, Satoru
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Mizuguchi, Hiroyuki
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2021, 112 : 399 - 399
  • [2] Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
    Fujiwara, Toshiyoshi
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    CURRENT CANCER THERAPY REVIEWS, 2015, 11 (03) : 178 - 187
  • [3] Novel therapeutic strategy with anti-PD-1 antibody and telomerase-specific oncolytic virotherapy in osteosarcoma
    Mochizuki, Yusuke
    Tazawa, Hiroshi
    Demiya, Koji
    Komatsubara, Tadashi
    Sugiu, Kazuhisa
    Hasei, Joe
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2018, 109 : 1167 - 1167
  • [4] Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody
    Kanaya, Nobuhiko
    Kuroda, Shinji
    Kakiuchi, Yoshihiko
    Kumon, Kento
    Tsumura, Tomoko
    Hashimoto, Masashi
    Morihiro, Toshiaki
    Kubota, Tetsushi
    Aoyama, Katsuyuki
    Kikuchi, Satoru
    Nishizaki, Masahiko
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    Mizuguchi, Hiroyuki
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    MOLECULAR THERAPY, 2020, 28 (03) : 794 - 804
  • [5] Combination therapy of telomerase-specific oncolytic adenovirus and zoledronic acid in human osteosarcoma cells
    Yamakawa, Yasuaki
    Hasei, Joe
    Tazawa, Hiroshi
    Omori, Toshinori
    Osaki, Shuhei
    Sasaki, Tsuyoshi
    Yoshida, Aki
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma
    Mochizuki, Yusuke
    Tazawa, Hiroshi
    Demiya, Koji
    Kure, Miho
    Kondo, Hiroya
    Komatsubara, Tadashi
    Sugiu, Kazuhisa
    Hasei, Joe
    Yoshida, Aki
    Kunisada, Toshiyuki
    Urata, Yasuo
    Kagawa, Shunsuke
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (05) : 1405 - 1417
  • [7] Exosomal E1A-DNA in serum as a predictive biomarker of telomerase-specific oncolytic adenovirus
    Yagi, Chiaki
    Kuroda, Shinji
    Yoshida, Yusuke
    Sakamoto, Masaki
    Hamada, Yuki
    Sugimoto, Ryoma
    Hashimoto, Masashi
    Kakiuchi, Yoshihiko
    Kikuchi, Satoru
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2023, 114 : 1725 - 1725
  • [8] Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma
    Yusuke Mochizuki
    Hiroshi Tazawa
    Koji Demiya
    Miho Kure
    Hiroya Kondo
    Tadashi Komatsubara
    Kazuhisa Sugiu
    Joe Hasei
    Aki Yoshida
    Toshiyuki Kunisada
    Yasuo Urata
    Shunsuke Kagawa
    Toshifumi Ozaki
    Toshiyoshi Fujiwara
    Cancer Immunology, Immunotherapy, 2021, 70 : 1405 - 1417
  • [9] Immunity-activating telomerase-specific oncolytic adenoviruses produce synergistic effects with anti-PD1 antibody
    Hashimoto, Masashi
    Kuroda, Shinji
    Kanaya, Nobuhiko
    Tsumura, Tomoko
    Kakiuchi, Yoshihiko
    Kikuchi, Satoru
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2022, 113 : 1252 - 1252
  • [10] Telomerase-specific oncolytic virotherapy promotes therapeuticefficacy of PD-1 blockade in murine osteosarcoma
    Mochizuki, Yusuke
    Tazawa, Hiroshi
    Demiya, Koji
    Komatsubara, Tadashi
    Sugiu, Kazuhisa
    Hasei, Joe
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2018, 78 (13)
12345